Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
12/1996
12/19/1996WO1996040762A1 Monocyte chemotactic protein-4
12/19/1996WO1996040750A1 Peptides and compounds that bind to a thrombopoietin receptor
12/19/1996WO1996040749A1 Compounds and peptides that bind to the erythropoietin receptor
12/19/1996WO1996040748A1 Peptidyl heterocycles useful in the treatment of thrombin related disorders
12/19/1996WO1996040744A1 KETOHETEROCYCLIC INHIBITORS OF FACTOR Xa
12/19/1996WO1996040743A2 INHIBITORS OF FACTOR Xa
12/19/1996WO1996040679A1 Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) n-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds
12/19/1996WO1996040638A1 Heteroaryl diol acids as leukotriene antagonists
12/19/1996WO1996040231A1 Method for obtaining receptor agonist antibodies
12/19/1996WO1996040218A1 Methods for increasing hematopoietic cells
12/19/1996WO1996040205A1 Metabolic effects of certain glutathione analogs
12/19/1996WO1996040152A1 Dehydroepiandrosterone derivatives for preventing progressive tissue necrosis reperfusion injury, bacterial translocation and adult respiratory distress syndrome
12/19/1996WO1996040123A1 Antigen-processing cell-targeted conjugates
12/19/1996WO1996040118A1 Thrombin inhibitors
12/19/1996WO1996040106A2 Methods for controlling highly unsaturated fatty acid content in various tissues
12/19/1996WO1996040098A2 Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
12/19/1996WO1996040073A2 Composition for sustained release of non-aggregated erythropoietin
12/19/1996WO1996039996A1 Method for regulating metabolism with dopamine beta hydroxylase inhibitors
12/19/1996WO1996039978A1 Therapeutic use of acetazolamide for the treatment of brain edema
12/19/1996WO1996029973A3 Compositions and methods for inhibiting thrombogenesis
12/19/1996CA2224180A1 Ketoheterocyclic inhibitors of factor xa
12/19/1996CA2224174A1 Method for obtaining receptor agonist antibodies
12/19/1996CA2224110A1 Peptidyl heterocycles useful in the treatment of thrombin related disorders
12/19/1996CA2224099A1 Monocyte chemotactic protein-4
12/19/1996CA2224076A1 Inhibitors of factor xa
12/19/1996CA2223834A1 Composition for sustained release of non-aggregated erythropoietin
12/19/1996CA2223739A1 Dehydroepiandrosterone derivatives for preventing progressive tissue necrosis reperfusion injury, bacterial translocation and adult respiratory distress syndrome
12/19/1996CA2223500A1 Thrombin inhibitors
12/19/1996CA2223143A1 Peptide fragments of tissue factor and their use for treatment and prevention of clotting disorders
12/19/1996CA2223046A1 Methods for increasing hematopoietic cells
12/19/1996CA2219981A1 Method for regulating metabolism with dopamine beta hydroxylase inhibitors
12/19/1996CA2219242A1 Modified hemoglobin-like compounds and methods of purifying same
12/19/1996CA2196873A1 Therapeutic use of acetazolamide for the treatment of brain edema
12/18/1996EP0748633A2 Adhesive tissue and its use as haemostyptic
12/18/1996EP0748380A1 KUNITZ DOMAIN INHIBITOR PROTEINS DERIVED FROM ALZHEIMER'S AMYLOID $g(b)-PROTEIN PRECURSOR INHIBITOR
12/18/1996EP0748333A1 Antithrombotic agents
12/18/1996EP0748317A1 Novel thiazolidin-4-one derivatives
12/18/1996EP0748215A1 Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use
12/18/1996EP0666736B1 Stabilization of fluorocarbon emulsions
12/18/1996EP0609242B1 New thrombin-inhibiting protein isolated from ticks
12/18/1996CN1138349A Human activated protein C preparation and process for producing the same
12/18/1996CN1138297A Method of stabilizing protein C or activated protein C and stabilized composition
12/18/1996CN1138037A Adhesion receptor antagonists
12/17/1996US5585361 Intravenous administration of hyaluronic acid or its salts
12/17/1996US5585360 Thrombin inhibitors
12/17/1996US5585350 Thrombin-inhibitory protein from ticks
12/13/1996CA2178789A1 Hemostyptic and tissue adhesive
12/12/1996WO1996039519A1 Kunitz type plasma kallikrein inhibitors
12/12/1996WO1996039509A1 Fibroblast growth factor 15
12/12/1996WO1996039442A1 G-protein receptor htnad29
12/12/1996WO1996039439A1 Human g-protein receptor hcegh45
12/12/1996WO1996039426A1 Hypoxia inducible factor-1 and method of use
12/12/1996WO1996039171A1 Therapy using lymphotoxin and thrombopoietin
12/12/1996WO1996039128A1 Protein particles for therapeutic and diagnostic use
12/12/1996CA2221706A1 G-protein receptor htnad29
12/12/1996CA2221637A1 Human g-protein receptor hcegh45
12/12/1996CA2220895A1 Protein particles for therapeutic and diagnostic use
12/12/1996CA2220336A1 Therapy using lymphotoxin and thrombopoietin
12/12/1996CA2220130A1 Kunitz type plasma kallikrein inhibitors
12/12/1996CA2217301A1 Fibroblast growth factor 15
12/11/1996EP0747050A1 Pharmaceutical compositions containing irbesartan
12/11/1996EP0746566A1 Novel 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
12/11/1996EP0746551A1 Optically pure 4-aryl-2-hydroxytetronic acids
12/11/1996EP0746545A1 Nipecotic acid derivatives as antithrombic compounds
12/11/1996EP0746334A1 Pharmaceutical preparation containing plasminogen activators
12/11/1996EP0646130B1 Selective crosslinking of hemoglobins by oxidized, ring-opened saccharides
12/11/1996EP0496832B1 Inhibition of padgem-mediated cell binding
12/11/1996CN1137757A Compositions and methods for stimulating megakaryocyte growth and differentiation
12/11/1996CN1137564A Stable transglutaminase preparations and processes for producing them
12/11/1996CN1137406A Yunan Baiyao (White Drug-Powder) tablet and preparation method thereof
12/11/1996CN1137393A Yisuishengxue Chinese medicine preparation for tonifying marrow and promoting generation of blood
12/10/1996US5583209 Produced by isolation and recombination of human and porcine factor viii
12/10/1996US5583133 Anticoagulants
12/10/1996US5583121 Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes
12/10/1996US5583113 Use of a direct-acting thrombin inhibitor for the manufacture of a medicinal product having thrombolytic activity
12/10/1996US5583111 Water soluble leech extract
12/10/1996US5583107 Agents affecting thrombosis and hemostasis
12/10/1996US5582823 Methods of treating bacterial inflammation and granulocytopoiesis by administering human pluripotent granulocyte colony-stimulating factor
12/10/1996US5582821 Administering interleukins
12/10/1996US5582591 Delivery of solid drug compositions
12/10/1996CA2104456C Pyridine- and imidazole-derived agents for cardiovascular diseases
12/10/1996CA2060507C Factor xa based anticoagulant compositions
12/10/1996CA2016949C Method and composition for the treatment of thrombosis in a mammal
12/05/1996WO1996038470A1 IMIDAZO[1,5a]PYRIDINE DERIVED SERINE PROTEASE INHIBITORS
12/05/1996WO1996038436A1 (2-thienyl)alkanoic acid derivatives
12/05/1996WO1996038426A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
12/05/1996WO1996038421A1 N,n-di(arylmethyl)cyclic urea derivatives as anti-coagulants
12/05/1996WO1996038416A1 (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy} butyric acid as cellular adhesion inhibitor
12/05/1996WO1996038136A1 Localized use of nitric oxide-adducts to prevent internal tissue damage
12/05/1996CA2222960A1 Imidazo 1,5a pyridine derived serine protease inhibitors
12/05/1996CA2222147A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
12/05/1996CA2221992A1 N,n-di(arylmethyl)cyclic urea derivatives as anti-coagulants
12/05/1996CA2194397A1 (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy} butyric acid as cellular adhesion inhibitor
12/04/1996EP0745125A1 Hematopoietic protein and materials and methods for making it
12/04/1996EP0745094A1 Superagonists and antagonists of h il-6, and 3d modelling method for their selection
12/04/1996EP0745070A1 Pharmaceutical piperazine compounds
12/04/1996EP0745069A1 Pharmaceutical piperazine compounds
12/04/1996EP0744953A1 Erythropoietin analog compositions and methods
12/04/1996EP0744952A1 Method for treating vascular obstructions caused by abnormal cells
12/04/1996EP0744950A1 Agent for prophylaxis and treatment of thromboxane a 2?-mediated diseases
1 ... 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 ... 671